Paper
WANG Haibo, FENG Zhong, ZHENG Jiafang, XUN Mingjin, ZHANG Guimin
To control the quality of relugolix(1), four process impurities were synthesized, namely
6-(4-aminophenyl)-1-(2,6-difluorobenzyl)-5-[(dimethylamino)methyl]-3-(6-oxo-1,4,5,6-tetrahydropyridazin-3-yl)-
thieno[2,3-d]pyrimidine-2,4(1H,3H)-dione (related substance A), 1-[4-[1-(2,6-difluorobenzyl)-5-[(dimethylamino)-
methyl]-2,4-dioxo-3-(6-oxo-1,4,5,6-tetrahydropyridazin-3-yl)-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidin-6-yl]-
phenyl]-3-methoxyurea(related substance B), 1,3-bis[4-[1-(2,6-difluorobenzyl)-5-[(dimethylamino)methyl]-3-(6-
methoxypyridazin-3-yl)-2,4-dioxo-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidin-6-yl]phenyl]urea (related substance C)
and 1,5-bis[4-[1-(2,6-difluorobenzyl)-5-[(dimethylamino)methyl]-3-(6-methoxypyridazin-3-yl)-2,4-dioxo-1,2,3,4-
tetrahydrothieno[2,3-d]pyrimidin-6-yl]phenyl]-3-methoxy biuret (related substance D). The related substances A and B
were reported at the first time. This article aimed to provide the reference substances for the quality research of 1, and also
to offer the insights for further optimization of the synthetic process of 1.